Skip to main content
C

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 Shenzhen Stock Exchange Professional, scientific and technical activities
Filings indexed 2,245 across all filing types
Latest filing 2021-04-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于开展外汇套期保值业务的公告
Regulatory Filings
2021-04-27 Chinese
年报披露提示性公告
Regulatory Filings
2021-04-27 Chinese
关于上海睿智化学研究有限公司2020年度业绩承诺实现情况及补偿方案暨关联交易的公告
Regulatory Filings
2021-04-27 Chinese
广发证券关于睿智医药发行股份及支付现金购买资产暨关联交易之2020年度业绩承诺实现情况的核查意见
Regulatory Filings
2021-04-27 Chinese
2020年年度审计报告
Regulatory Filings
2021-04-27 Chinese
套期保值业务内部控制制度(2021年4月)
Regulatory Filings
2021-04-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.